Association between maternal and child leptin levels 9 years after pregnancy complicated by gestational diabetes

M P Malee1, A Verma, G Messerlian

  • 1Department of Obstetrics and Gynecology, Women and Infants' Hospital, Brown Medical School, 101 Dudley Street, Providence, RI, USA.

Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|May 3, 2002
PubMed

Insights

Maternal gestational diabetes mellitus (GDM) is linked to higher child leptin levels nine years later. Elevated child leptin in offspring of GDM mothers correlates with maternal leptin, suggesting a long-term association.

Area of Science:

  • Endocrinology
  • Pediatrics
  • Metabolic Disorders

Background:

  • Obesity is linked to leptin resistance and increased type 2 diabetes risk.
  • Children born to mothers with gestational diabetes mellitus (GDM) have a higher risk of obesity.
  • Leptin plays a crucial role in regulating appetite and energy balance.

Purpose of the Study:

  • To investigate the association between maternal and child leptin levels 9 years post-delivery in mothers with and without GDM.
  • To determine if child leptin levels at age 9 can serve as an early marker for insulin resistance.

Main Methods:

  • A cohort study of 64 mothers (33 GDM, 31 controls) and their 9-year-old offspring.
  • Analysis of maternal and child leptin levels, child body mass index (BMI), and child fasting insulin.
  • Statistical analyses including univariate and multivariate correlations.

Main Results:

  • Child leptin levels were significantly correlated with maternal leptin levels only in the offspring of GDM mothers (r = 0.59, p = 0.001).
  • Multivariate analysis showed child leptin associated with child BMI (R(2) = 0.65), child fasting insulin (R(2) = 0.08), and female gender (R(2) = 0.28).
  • Among offspring of GDM mothers, child leptin was associated with maternal leptin (R(2) = 0.14).

Conclusions:

  • A significant association exists between maternal and child leptin levels 9 years after pregnancies complicated by gestational diabetes.
  • Child leptin may be an indicator of metabolic changes related to maternal GDM exposure.
  • Further research is warranted to explore the long-term metabolic implications for offspring exposed to GDM in utero.

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...